68 related articles for article (PubMed ID: 15036224)
1. Sex steroids and age-related macular degeneration in older French women: the POLA study.
Defay R; Pinchinat S; Lumbroso S; Sutan C; Delcourt C;
Ann Epidemiol; 2004 Mar; 14(3):202-8. PubMed ID: 15036224
[TBL] [Abstract][Full Text] [Related]
2. Relationships between hormonal status and cataract in french postmenopausal women: the POLA study.
Defay R; Pinchinat S; Lumbroso S; Sultan C; Papoz L; Delcourt C;
Ann Epidemiol; 2003 Oct; 13(9):638-44. PubMed ID: 14732303
[TBL] [Abstract][Full Text] [Related]
3. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study.
Delcourt C; Lacroux A; Carrière I;
Am J Ophthalmol; 2005 Nov; 140(5):924-6. PubMed ID: 16310477
[TBL] [Abstract][Full Text] [Related]
4. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
6. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study.
Delcourt C; Carrière I; Delage M; Barberger-Gateau P; Schalch W;
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2329-35. PubMed ID: 16723441
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: the Salisbury Eye Evaluation Project.
Freeman EE; Muñoz B; Bressler SB; West SK
Ophthalmic Epidemiol; 2005 Feb; 12(1):37-45. PubMed ID: 15848919
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study.
Kawasaki R; Wang JJ; Ji GJ; Taylor B; Oizumi T; Daimon M; Kato T; Kawata S; Kayama T; Tano Y; Mitchell P; Yamashita H; Wong TY
Ophthalmology; 2008 Aug; 115(8):1376-81, 1381.e1-2. PubMed ID: 18222000
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India.
Krishnaiah S; Das T; Nirmalan PK; Nutheti R; Shamanna BR; Rao GN; Thomas R
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4442-9. PubMed ID: 16303932
[TBL] [Abstract][Full Text] [Related]
10. Five-year incidence of age-related maculopathy: the Visual Impairment Project.
Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR
Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968
[TBL] [Abstract][Full Text] [Related]
11. Retinal vessel diameters and the risk of incident age-related macular disease: the Rotterdam Study.
Ikram MK; van Leeuwen R; Vingerling JR; Hofman A; de Jong PT
Ophthalmology; 2005 Apr; 112(4):548-52. PubMed ID: 15808242
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study.
Tikellis G; Robman LD; Dimitrov P; Nicolas C; McCarty CA; Guymer RH
Eye (Lond); 2007 Feb; 21(2):169-76. PubMed ID: 16732219
[TBL] [Abstract][Full Text] [Related]
13. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.
Tamer C; Oksuz H; Söğüt S
Am J Ophthalmol; 2007 Feb; 143(2):212-216. PubMed ID: 17157799
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study.
Gupta SK; Murthy GV; Morrison N; Price GM; Dherani M; John N; Fletcher AE; Chakravarthy U
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1007-11. PubMed ID: 17325139
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study.
Björnsson OM; Syrdalen P; Bird AC; Peto T; Kinge B
Acta Ophthalmol Scand; 2006 Oct; 84(5):636-41. PubMed ID: 16965494
[TBL] [Abstract][Full Text] [Related]
16. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
17. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age.
Delcourt C; Cristol JP; Tessier F; Léger CL; Descomps B; Papoz L
Arch Ophthalmol; 1999 Oct; 117(10):1384-90. PubMed ID: 10532448
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma homocysteine and risk of age-related macular degeneration.
Seddon JM; Gensler G; Klein ML; Milton RC
Am J Ophthalmol; 2006 Jan; 141(1):201-3. PubMed ID: 16387004
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of age-related macular degeneration.
Klein R; Peto T; Bird A; Vannewkirk MR
Am J Ophthalmol; 2004 Mar; 137(3):486-95. PubMed ID: 15013873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
